• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

梗死前心绞痛对接受成功溶栓治疗的急性心肌梗死患者临床再灌注时间的影响。

The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.

作者信息

Evrengul Harun, Celek Turgay, Tanriverdi Halil, Kaftan Asuman, Dursunoglu Dursun, Kilic Mustafa

机构信息

Department of Cardiology, Pamukkale University School of Medicine, Denizli, Turkey.

出版信息

Can J Cardiol. 2005 Sep;21(11):915-20.

PMID:16239974
Abstract

BACKGROUND

Preinfarction angina (PA) and early reperfusion of infarct-related arteries have been shown to reduce infarct size in patients with acute myocardial infarction (AMI). The beneficial effects of PA on infarct size have been attributed to the development of ischemic preconditioning and faster coronary recanalization in patients treated with thrombolytic therapy (TT).

OBJECTIVE

To evaluate the effect of PA on clinical coronary reperfusion time in patients with AMI receiving successful TT.

METHODS

Seventy-five patients presenting with AMI (within 6 h after the initial onset of symptoms) were studied. All patients received TT and were evaluated with coronary angiography (CA) at predischarge. The patients were divided into two groups: group 1 (PA-positive) comprised those who experienced a new onset of prodromal angina within 72 h before the onset of AMI. Group 2 (PA-negative) comprised those who had a sudden onset of AMI without the preceding angina. The successful myocardial reperfusion criteria after TT were ST segment resolution of 50% or greater, the appearance of reperfusion arrhythmias and the resolution of chest pain. The time of reperfusion criteria was recorded after TT. CA was performed in all patients at predischarge. Patients with no patent infarct-related arteries on CA and clinical failure of reperfusion were excluded from the study.

RESULTS

Clinical characteristics, risk factors and angiographic findings did not differ significantly between the groups. The time interval from the start of continuous chest pain to TT was also similar between the groups. The left ventricular ejection fraction was higher and there were less frequent ventricular arrhythmias in patients with PA than in those without PA (47.9+/-7.4 versus 44.4+/-8.1, P=0.041, and 17.1% versus 37.5%, P=0.043, respectively). The clinical reperfusion time was significantly shorter in the patients with PA than in those without PA (68.2+/-24.5 min versus 81.4+/-19.3, P=0.012). The clinical reperfusion time was positively correlated with age and the time interval from the start of continuous chest pain to TT but inversely related to the presence of PA.

CONCLUSIONS

In patients with AMI preceded by PA, TT resulted in more rapid clinical reperfusion than in patients without PA. Thus, earlier myocardial reperfusion may account for smaller infarct size and better prognosis in patients with PA.

摘要

背景

梗死前心绞痛(PA)和梗死相关动脉的早期再灌注已被证明可减小急性心肌梗死(AMI)患者的梗死面积。PA对梗死面积的有益作用归因于缺血预处理的发展以及接受溶栓治疗(TT)患者冠状动脉再通更快。

目的

评估PA对接受成功TT治疗的AMI患者临床冠状动脉再灌注时间的影响。

方法

研究了75例出现AMI(症状初始发作后6小时内)的患者。所有患者均接受TT治疗,并在出院前进行冠状动脉造影(CA)评估。患者分为两组:第1组(PA阳性)包括那些在AMI发作前72小时内出现前驱性心绞痛新发的患者。第2组(PA阴性)包括那些突然发作AMI且无前驱心绞痛的患者。TT治疗后成功心肌再灌注的标准为ST段回落≥50%、出现再灌注心律失常和胸痛缓解。记录TT治疗后达到再灌注标准的时间。所有患者在出院前进行CA检查。CA显示梗死相关动脉未开通且临床再灌注失败的患者被排除在研究之外。

结果

两组患者的临床特征、危险因素和血管造影结果无显著差异。两组从持续胸痛开始至TT的时间间隔也相似。PA患者的左心室射血分数较高,室性心律失常发生率低于无PA患者(分别为47.9±7.4对44.4±8.1,P = 0.041;17.1%对37.5%,P = 0.043)。PA患者的临床再灌注时间显著短于无PA患者(68.2±24.5分钟对8 /1.4±19.3,P = 0.012)。临床再灌注时间与年龄以及从持续胸痛开始至TT的时间间隔呈正相关,但与PA的存在呈负相关。

结论

在有PA前驱的AMI患者中,TT导致的临床再灌注比无PA患者更快。因此,更早的心肌再灌注可能是PA患者梗死面积较小和预后较好的原因。

相似文献

1
The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.梗死前心绞痛对接受成功溶栓治疗的急性心肌梗死患者临床再灌注时间的影响。
Can J Cardiol. 2005 Sep;21(11):915-20.
2
Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction.梗死前心绞痛作为急性心肌梗死患者冠状动脉溶栓更迅速的预测指标。
N Engl J Med. 1996 Jan 4;334(1):7-12. doi: 10.1056/NEJM199601043340102.
3
[The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].急性心肌梗死全身挽救性溶栓治疗的安全性与有效性
Ital Heart J Suppl. 2000 Jan;1(1):81-7.
4
Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.急性心肌梗死中阿替普酶(50毫克)联合替罗非班溶栓与单独使用阿替普酶(100毫克)溶栓的安全性和有效性:初步研究结果。
Ital Heart J. 2001 Aug;2(8):605-11.
5
Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase.随机分配接受直接经皮冠状动脉介入治疗或链激酶治疗的急性心肌梗死患者的早期再灌注及晚期临床结局
Am Heart J. 2003 Dec;146(6):E22. doi: 10.1016/S0002-8703(03)00424-1.
6
[Effect of delaying reperfusion therapy with PTCA on long term prognosis in patients with acute myocardial infarct].[经皮冠状动脉腔内血管成形术延迟再灌注治疗对急性心肌梗死患者长期预后的影响]
Vnitr Lek. 2003 Jan;49(1):51-60.
7
Accelerated intravenous dosing of recombinant tissue-type plasminogen activator causes rapid but unstable reperfusion in a canine model of acute myocardial infarction.在急性心肌梗死犬模型中,加速静脉注射重组组织型纤溶酶原激活剂可导致快速但不稳定的再灌注。
Coron Artery Dis. 1994 Nov;5(11):929-36.
8
[Effect of the collateral circulation on myocardial salvage in patients with acute myocardial infarction].[侧支循环对急性心肌梗死患者心肌挽救的影响]
J Cardiol. 1991;21(1):1-13.
9
Eligibility of patients with acute myocardial infarction for thrombolytic therapy: retrospective cohort study.急性心肌梗死患者接受溶栓治疗的资格:回顾性队列研究。
Croat Med J. 2000 Dec;41(4):401-5.
10
Multiple episodes of ischemic preconditioning are not associated with loss of benefit: preliminary clinical experience.多次缺血预处理发作与获益丧失无关:初步临床经验
Can J Cardiol. 2005 Dec;21(14):1291-5.

引用本文的文献

1
One-Year Outcome of Patients with Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks.接受经皮冠状动脉介入治疗的冠状动脉扩张患者的一年结局:临床意义与疑问
J Tehran Heart Cent. 2020 Oct;15(4):171-177. doi: 10.18502/jthc.v15i4.5943.
2
DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning.二肽基肽酶-4(DPP-4)酶缺乏可保护肾脏免受急性缺血再灌注损伤:远程间歇性肠缺血再灌注预处理的作用。
Oncotarget. 2017 Jul 4;8(33):54821-54837. doi: 10.18632/oncotarget.18962. eCollection 2017 Aug 15.
3
Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST).
心绞痛和血压对合并冠心病的高血压患者死亡率的影响:国际维拉帕米/曲多普利研究(INVEST)扩展随访的新数据。
Clin Cardiol. 2013 Aug;36(8):442-7. doi: 10.1002/clc.22145. Epub 2013 May 29.